Acute liver failure caused by concurrent autoimmune hepatitis and hepatitis B in a 16-year old girl

由 Pawłowska, Małgorzata, Halota, Waldemar
出版 2010

Vertical genotype 1 HCV infection treated successfully in the second year of life: A case report

由 Pawłowska, Małgorzata, Halota, Waldemar, Smukalska, Ewa
出版 2012

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

由 Kozielewicz, Dorota, Halota, Waldemar, Wietlicka-Piszcz, Magdalena
發表在 Hepatol Int (2015)

Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz

由 Tyczyno, Malgorzata, Halota, Waldemar, Nowak, Wojciech, Pawlowska, Małgorzata
出版 2014

Hematological Adverse events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection

由 Pawlowska, Malgorzata, Pilarczyk, Malgorzata, Foksinska, Anna, Smukalska, Ewa, Halota, Waldemar
出版 2011

The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepa...

由 Domagalski, Krzysztof, Pawłowska, Małgorzata, Kozielewicz, Dorota, Dybowska, Dorota, Tretyn, Andrzej, Halota, Waldemar
發表在 PLoS One (2015)

What’s new in hepatitis C virus infections in children?

由 Pawlowska, Malgorzata, Domagalski, Krzysztof, Pniewska, Anna, Smok, Beata, Halota, Waldemar, Tretyn, Andrzej
發表在 World J Gastroenterol (2015)

Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4

由 Domagalski, Krzysztof, Pawlowska, Magorzata, Tretyn, Andrzej, Halota, Waldemar, Tyczyno, Magorzata, Kozielewicz, Dorota, Dybowska, Dorota
出版 2013

Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus

由 Domagalski, Krzysztof, Pawłowska, Małgorzata, Zaleśna, Agnieszka, Pilarczyk, Małgorzata, Rajewski, Paweł, Halota, Waldemar, Tretyn, Andrzej
發表在 World J Gastroenterol (2016)

Recommendations for the treatment of hepatitis C in 2017

由 Halota, Waldemar, Flisiak, Robert, Juszczyk, Jacek, Małkowski, Piotr, Pawłowska, Małgorzata, Simon, Krzysztof, Tomasiewicz, Krzysztof
發表在 Clin Exp Hepatol (2017)

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

由 Halota, Waldemar, Flisiak, Robert, Juszczyk, Jacek, Małkowski, Piotr, Pawłowska, Małgorzata, Simon, Krzysztof, Tomasiewicz, Krzysztof
發表在 Clin Exp Hepatol (2020)

Continuous up to 4 Years Entecavir Treatment of HBV-Infected Adolescents – A Longitudinal Study in Real Life

由 Pawłowska, Małgorzata, Domagalski, Krzysztof, Smok, Beata, Rajewski, Paweł, Wietlicka-Piszcz, Magdalena, Halota, Waldemar, Tretyn, Andrzej
發表在 PLoS One (2016)

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts – 2016

由 Halota, Waldemar, Flisiak, Robert, Boroń-Kaczmarska, Anna, Juszczyk, Jacek, Małkowski, Piotr, Pawłowska, Małgorzata, Simon, Krzysztof, Tomasiewicz, Krzysztof
發表在 Clin Exp Hepatol (2016)

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts – 2015

由 Halota, Waldemar, Flisiak, Robert, Boroń-Kaczmarska, Anna, Juszczyk, Jacek, Pawłowska, Małgorzata, Simon, Krzysztof, Tomasiewicz, Krzysztof, Małkowski, Piotr
發表在 Clin Exp Hepatol (2015)

Recommendations for the treatment of hepatitis B in 2017

由 Flisiak, Robert, Halota, Waldemar, Jaroszewicz, Jerzy, Juszczyk, Jacek, Małkowski, Piotr, Pawłowska, Małgorzata, Piekarska, Anna, Simon, Krzysztof, Tomasiewicz, Krzysztof, Wawrzynowicz-Syczewska, Marta
發表在 Clin Exp Hepatol (2017)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)

由 Tomasiewicz, Krzysztof, Flisiak, Robert, Halota, Waldemar, Jaroszewicz, Jerzy, Lebensztejn, Dariusz, Lisik, Wojciech, Małkowski, Piotr, Pawłowska, Małgorzata, Piekarska, Anna, Simon, Krzysztof, Tronina, Olga
發表在 Clin Exp Hepatol (2018)

Searching for the optimal population for hepatitis C virus screening in Poland

由 Piekarska, Anna, Tomasiewicz, Krzysztof, Halota, Waldemar, Jaroszewicz, Jerzy, Krygier, Rafał, Małkowski, Piotr, Pawłowska, Małgorzata, Simon, Krzysztof, Tronina, Olga, Zarębska-Michaluk, Dorota, Flisiak, Robert
發表在 Clin Exp Hepatol (2020)

Distribution of HBV genotypes in Poland

由 Świderska, Magdalena, Pawłowska, Małgorzata, Mazur, Włodzimierz, Tomasiewicz, Krzysztof, Simon, Krzysztof, Piekarska, Anna, Wawrzynowicz-Syczewska, Marta, Jaroszewicz, Jerzy, Rajewski, Paweł, Zasik, Ewelina, Murias-Bryłowska, Elżbieta, Pniewska, Anna, Halota, Waldemar, Flisiak, Robert
發表在 Clin Exp Hepatol (2015)

Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study

由 Tronina, Olga, Durlik, Magdalena, Orłowska, Iwona, Lorenc, Beata, Łapiński, Tadeusz W., Garlicki, Aleksander, Dybowska, Dorota, Zarębska-Michaluk, Dorota, Tudrujek-Zdunek, Magdalena, Citko, Jolanta, Janczewska, Ewa, Kaczmarczyk, Marcin, Jaroszewicz, Jerzy, Krygier, Rafał, Klapaczyński, Jakub, Dobracka, Beata, Białkowska-Warzecha, Jolanta, Piekarska, Anna, Simon, Krzysztof, Halota, Waldemar, Pawłowska, Małgorzata, Tomasiewicz, Krzysztof, Flisiak, Robert
發表在 Ann Gastroenterol (2021)

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

由 Janczewska, Ewa, Kołek, Mateusz Franciszek, Lorenc, Beata, Klapaczyński, Jakub, Tudrujek-Zdunek, Magdalena, Sitko, Marek, Mazur, Włodzimierz, Zarębska-Michaluk, Dorota, Buczyńska, Iwona, Dybowska, Dorota, Czauż-Andrzejuk, Agnieszka, Berak, Hanna, Krygier, Rafał, Jaroszewicz, Jerzy, Citko, Jolanta, Piekarska, Anna, Dobracka, Beata, Socha, Łukasz, Deroń, Zbigniew, Laurans, Łukasz, Białkowska-Warzecha, Jolanta, Tronina, Olga, Adamek, Brygida, Tomasiewicz, Krzysztof, Simon, Krzysztof, Pawłowska, Malgorzata, Halota, Waldemar, Flisiak, Robert
發表在 World J Gastroenterol (2021)